| scholarly article | Q13442814 |
| P50 | author | Paul Emery | Q19859634 |
| P2093 | author name string | Bradley H | |
| Waring R | |||
| Gough A | |||
| Jubb R | |||
| Arthur V | |||
| P2860 | cites work | Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. | Q34621815 |
| Poor sulphoxidation ability in patients with food sensitivity | Q35700780 | ||
| The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine | Q38692075 | ||
| Effects of antirheumatic drugs on protein sulphydryl reactivity of human serum | Q39282861 | ||
| Pharmacogenetics of the S-oxidation of S-carboxymethyl-L-cysteine | Q39584101 | ||
| Measurement of sulphated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid | Q41205193 | ||
| Does sulphoxidation state predict gold toxicity in rheumatoid arthritis? | Q42556954 | ||
| Metabolism of low-dose paracetamol in patients with rheumatoid arthritis | Q68056466 | ||
| False positives with current carbocisteine protocol for sulphoxidation phenotyping | Q68086524 | ||
| High incidence of poor sulfoxidation in patients with primary biliary cirrhosis | Q68131025 | ||
| Xenobiotic metabolism in motor neuron disease | Q69923802 | ||
| D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3 | Q70230289 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 318-320 | |
| P577 | publication date | 1992-03-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment | |
| P478 | volume | 51 |
| Q35824794 | Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis |
| Q28569668 | Hepatic localisation of rat cysteine dioxygenase |
| Q33984090 | Heterologous expression, purification, and characterization of recombinant rat cysteine dioxygenase. |
| Q35838724 | Management of early inflammatory arthritis. Genetic factors predicting persistent disease: the role of defective enzyme systems |
| Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
| Q36272648 | Spectroscopic and Computational Investigation of the H155A Variant of Cysteine Dioxygenase: Geometric and Electronic Consequences of a Third-Sphere Amino Acid Substitution |
| Q34036729 | Spectroscopic and computational characterization of substrate-bound mouse cysteine dioxygenase: nature of the ferrous and ferric cysteine adducts and mechanistic implications |
| Q37682106 | Spectroscopic and computational characterization of the NO adduct of substrate-bound Fe(II) cysteine dioxygenase: insights into the mechanism of O2 activation |
| Q34193868 | Spectroscopic and computational investigation of iron(III) cysteine dioxygenase: implications for the nature of the putative superoxo-Fe(III) intermediate |
| Q41260232 | Sulphoxidation status in rheumatoid arthritis. |
| Q43822806 | Synthesis, X-ray Structures, Electronic Properties, and O2/NO Reactivities of Thiol Dioxygenase Active-Site Models |
Search more.